- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The JAK2 V617F mutation in isolated neutropenia ; Vol. 17 2018
EXCLI journal ; Vol. 17 2018
- Classification
-
Medizin, Gesundheit
- Creator
-
Langabeer, Stephen E.
- Handle
-
2003/36919
- URN
-
urn:nbn:de:101:1-2018062203463284861172
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langabeer, Stephen E.
Other Objects (12)
A novel germline hyperactivating JAK2 mutation L604F
The JAK2 V617F mutation in retinal vein or artery occlusion
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
Die Bedeutung der aktivierenden Mutation JAK2 V617F bei chronisch-myeloproliferativen Syndromen
Prävalenz und klinische Bedeutung der JAK2-V617F-Mutation in einem selektionierten Patientenkollektiv
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
Severe congenital neutropenia caused by the ELANE gene mutation in a Vietnamese boy with misdiagnosis of tuberculosis and autoimmune neutropenia: a case report
Etablierung und Anwendung eines JAK2, MPL, CALR NGS Panels im Rahmen der Studie: „Prävalenz von JAK2-Mutationen bei Patienten mit abdominalen Venenthrombosen“
JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report
JAK2 Negative Polycythemia Vera
A novel germline hyperactivating JAK2 mutation L604F
The JAK2 V617F mutation in retinal vein or artery occlusion
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
Die Bedeutung der aktivierenden Mutation JAK2 V617F bei chronisch-myeloproliferativen Syndromen
Prävalenz und klinische Bedeutung der JAK2-V617F-Mutation in einem selektionierten Patientenkollektiv
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
Severe congenital neutropenia caused by the ELANE gene mutation in a Vietnamese boy with misdiagnosis of tuberculosis and autoimmune neutropenia: a case report
Etablierung und Anwendung eines JAK2, MPL, CALR NGS Panels im Rahmen der Studie: „Prävalenz von JAK2-Mutationen bei Patienten mit abdominalen Venenthrombosen“
JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report
JAK2 Negative Polycythemia Vera
A novel germline hyperactivating JAK2 mutation L604F
The JAK2 V617F mutation in retinal vein or artery occlusion
JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association?
Die Bedeutung der aktivierenden Mutation JAK2 V617F bei chronisch-myeloproliferativen Syndromen
Prävalenz und klinische Bedeutung der JAK2-V617F-Mutation in einem selektionierten Patientenkollektiv
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
Severe congenital neutropenia caused by the ELANE gene mutation in a Vietnamese boy with misdiagnosis of tuberculosis and autoimmune neutropenia: a case report
Etablierung und Anwendung eines JAK2, MPL, CALR NGS Panels im Rahmen der Studie: „Prävalenz von JAK2-Mutationen bei Patienten mit abdominalen Venenthrombosen“
JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report